Raymond J. Furey
Executive VP, Chief Compliance Officer, General Counsel & Corporate SecretaryMr. Raymond J. Furey, J.D., also known as Ray, serves as Executive Vice President, General Counsel and Corporate Secretary for Rigel Pharmaceuticals, Inc. since December 2022 and serves as its Chief Compliance Officer since August 2023. He was Senior Vice President and Chief Compliance Officer at Turning Point Therapeutics, Inc. from March 2021 to August 2022 and served as Interim General Counsel in 2022. In his prior positions, Mr. Furey oversaw various companies’ legal affairs and managed their in-house legal teams. Mr. Furey served as the Chief Compliance Officer and Senior Vice President at Mallinckrodt public limited company since August 2014. Mr. Furey served as the Chief Compliance Officer of Questcor Pharmaceuticals, Inc. since October 2011 and has been its Senior Vice President since May 23, 2013. He served as Vice President of Compliance at Questcor Pharmaceuticals, Inc. from October 2011 to May 23, 2013. Prior to that, he was Senior Vice President and Chief Compliance Officer at Portola Pharmaceuticals from August 2017 to September 2020. He joined Questcor in October 2011. He is responsible for healthcare compliance program. Prior to joining Turning Point Pharmaceutics, Mr. Furey held various positions including Chief Operating Officer at Ara Pharmaceuticals from September 2020 to March 2021. He has extensive experience in the pharmaceutical space. He has held other senior level positions at Mallinckrodt Pharmaceuticals and Questor Pharmaceuticals. He served as the Corporate Compliance Officer at OSI Pharmaceuticals in New York. Prior to OSI, he spent 17 years at Genentech in South San Francisco in various capacities including healthcare compliance, commercial operations, finance, regulatory compliance and manufacturing. Mr. Furey earned his J.D. from Fordham University School of Law, his M.B.A. from San Francisco State University and his B.A. in Natural Sciences from Trinity College Dublin. He is also a Certified Fraud Examiner (CFE).
Positions
- Company NameRigel Pharmaceuticals, Inc.Stock CodeRIGLPositionExecutive VP, Chief Compliance Officer, General Counsel & Corporate SecretaryColleagues
- RRRaul R. RodriguezPresident, CEO & Director
- GAGregory Anthony LapointeIndependent Chairman of the Board
- DLDean L. SchornoExecutive VP & CFO
- DADavid A. SantosExecutive VP & Chief Commercial Officer
- ALAlison L. HannahExecutive VP & Chief Medical Officer
- WHWalter H. MoosIndependent Director
- JWJane WasmanIndependent Director
- KAKamil Ali JacksonIndependent Director
